Abstract
Since the reaction of neurochemists to immunology, and specifically to the immunology of gangliosides, may involve a time-delayed reversal of enthusiasm, we hope this survey will be an aid in tempering this reaction. There is a story told that on one occasion when ships of the British Navy were passing in review, one ship had the misfortune to commit six successive blunders. All eyes turned to the flagship anticipating the admiral’s horrendous reaction and were hopelessly puzzled when his signal flashed “Good”. A full twenty seconds later the message was completed by the word “God”. Although the interval in working in the field of immunology is much longer than twenty seconds, the complete message is often the same.
Preview
Unable to display preview. Download preview PDF.
References
P. J. Richardson, J. H. Walker, R. T. Jones, and V. P. Whittaker, Identification of a cholinergic-specific antigen chol-1 as a ganglioside, J. Neurochem. 38:1605 (1982).
G. S. Eisenbarth, F. S. Walsh, and M. Nirenberg, Monoclonal antibody to a plasma membrane antigen of neurons, Proc. Natl. Acad. Sci. USA 76:4913 (1979).
C. S. Pukel, K. O. Lloyd, L. R. Trabassos, W. G. Dippold, H. F. Oettgen, and L. F. Old, GD3, A prominent ganglioside of human melanoma: detection and characterization by a mouse monoclonal antibody, J. Exp. Med. 155:1133 (1982).
E. Nudelman, S. Hakomori, R. Kannagi, S. Levery, M. Y. Yeh, K. E. Hellstrom, and I. Hellstrom, Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2, J. Biol. Chem. 257:12752 (1982).
L. D. Cahan, R. F. Irie, R. Singh, A. Cassidenti, and J. C. Paulson, Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2, Proc. Natl. Acad. Sci. USA 79:7629 (1982).
T. Tai, J. C. Paulson, L. D. Cahan, and R. F. Irie, Ganglioside GM2 as a human tumor antigen (OFA-I-1), Proc. Natl. Acad. Sci. USA 80:5392 (1983).
J. L. Magnani, B. Nilsson, M. Brockhaus, D. Zopf, Z. Steplewski, H. Koprowski, and V. Ginsburg, A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II, J. Biol. Chem. 257:14365 (1982).
M. M. Rapport, L. Graf, Y. L. Huang, W. Brunner, and R. K. Yu, Antibodies to total brain gangliosides: titer and specificity of antisera, in: “Structure and Function of Gangliosides”, L. Svennerholm, P. Mandel, H. Dreyfus, and P. F. Urban, eds., Plenum Press, New York, p. 327 (1980).
M. Naiki, D. M. Marcus, and R. Ledeen, Properties of antisera to ganglioside GM1 and asialo GM1, J. Immunol. 113:84 (1974).
N. A. Gregson and C. T. Hammer, Antibodies against defined nerve cell components: gangliosides, J. Roy. Soc. Med. 73:501 (1980).
S. K. Kundu, D. M. Marcus, and R. W. Veh, Preparation and properties of antibodies to GD3 and GM1 gangliosides, J. Neurochem. 34:184 (1980).
I. Mioshi, Y. Fujii, and M. Naiki, Avian antisera to various gangliosides: detection by enzyme immunoassay, J. Biochem. 92:89 (1982).
T. A. Pascal, A. Saifer, and J. Gitlin, Immunochemical studies on normal and Tay-Sachs brain gangliosides, Proc. Soc. Exp. Biol. Med. 121:739 (1966).
R. A. Laine, G. Yogeeswaran, and S. Hakomori, Glycosphingolipids covalently linked to agarose gel or glass beads, J. Biol. Chem. 249:4460 (1974).
R. I. Jacobson, N. Kasai, F. F. Richards, and R. K. Yu, Preparation of anti-GM4 antiserum and its assay by a solid phase radioimmunoassay, J. Neuroimmunol. 3:225 (1982).
N. A. Gregson and C. T. Hammer, Some immunological properties of antisera raised against the trisialoganglioside GT1b, Molec. Immunol. 19:543 (1982).
S. Hakomori, Monoclonal antibodies directed to cell surface carbohydrates, in: “Hybridoma and Functional Cell Lines”, R. H. Kennett, K. B. Bechtol, and J. McKearn, eds., Plenum Press, New York (1984).
R. K. Yu and N. Kasai, The monoclonal antibody A2B5 is specific to ganglioside GQ1c, J. Neurochem. 41:S 122B (1983).
P. Fredman, J. L. Magnani, G. B. Grunwald, G. D. Trisler, M. Nirenberg, and V. Ginsberg, Monoclonal antibodies A2B5(105) and 18B8 react with many gangliosides in neuronal tissue, in: “Glycoconjugates, Proc. 7th Internat. Symp.”, M. A. Chester, D. Heinegard, A. Lundblad, and S. Svensson, eds., Lund-Ronneby, Sweden, p. 242 (1983).
G. D. Hunter and A. J. Dunn, Ganglioside patterns of the embryonic chick optic tectum: molecular heterogeneity and developmental time course, J. Neurochem. 41:S 151B (1983).
J. E. Butler, T. L. Feldbush, P. L. McGirern, and N. Stewart, The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity?, Immunochem. 15:131 (1978).
M. M. Rapport, S. E. Karpiak, and S. P. Mahadik, Biological activities of antibodies injected into the brain, Fed. Proc. 38:2391 (1979).
S. E. Karpiak, S. P. Mahadik, L. Graf, and M. M. Rapport, An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside, Epilepsia 22:189 (1981).
S. E. Karpiak, Y. L. Huang, and M. M. Rapport, Immunological model of epilepsy. Epileptiform activity induced by fragments of antibody to GM1 ganglioside, J. Neuroimmunol. 3:15 (1982).
S. E. Karpiak, Antibodies to GM1 ganglioside inhibit morphine analgesia, Pharm. Biochem. Behav. 16:611 (1982).
S. E. Karpiak and M. M. Rapport, Inhibition of consolidation and retrieval stages of passive-avoidance learning by antibodies to gangliosides, Behav. Neur. Biol. 27:146 (1979).
B. Frieder and M. M. Rapport, Enhancement of depolarization-induced release of GABA from brain slices by antibodies to ganglioside, J. Neurochem. 37:634 (1981).
M. Schwartz and N. Spirman, Sprouting from chicken embryo dorsal root ganglia induced by nerve growth factor is specifically inhibited by affinity-purified antiganglioside antibodies, Proc. Natl. Acad. Sci. USA 79:6080 (1982).
F. J. Roisen, M. M. Rapport, Y. Huang, and G. Yorke, Ganglioside mediation of NGF enhanced neuronal maturation, Soc. Neurosci. Abstr. 9:615 (1983).
J. Holgersson, K.-A. Karlsson, P. Karlsson, M. Ringqvist, N. Stromberg, J. Thurin, M. Blaszczyk, M. Herlyn, Z. Steplewski, and H. Koprowski, Mouse monoclonal antibodies with specificity for human melanoma cells are directed against hitherto unknown disialogangliosides, in: “Glycoconjugates, Proc. 7th Internat. Symp.”, M. A. Chester, D. Heinegard, A. Lundblad, and S. Svensson, eds., Lund-Ronneby, Sweden, p. 856 (1983).
C. De Baecque, A. B. Johnson, M. Naiki, G. Schwarting, and D. M. Marcus, Ganglioside localization in cerebellar cortex: an immunoperoxidase study with antibody to GM1 ganglioside, Brain Res. 114:117 (1976).
H. Laev, M. M. Rapport, S. P. Mahadik, and A. J. Silverman, Immunohistological localization of ganglioside in rat cerebellum, Brain Res. 157:136 (1978).
M. C. Raff, K. L. Fields, S. Hakomori, R. Mirsky, R. M. Pruss, and J. Winter, Cell-type specific markers for distinguishing and studying neurons and the major classes of glial cells in culture, Brain Res. 174:283 (1979).
H.-A. Hansson, J. Holmgren, and L. Svennerholm, Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin, Proc. Natl. Acad. Sci. USA 74:3782 (1977).
M. Willinger and M. Schachner, GM1 ganglioside as a marker for neuronal differentiation in mouse cerebellum, Dev. Biol. 74:101 (1980).
M. Willinger, The expression of GM1 ganglioside during neuronal differentiation, in: “Gangliosides in Neurological and Neuromuscular Function, Development and Repair”, M. M. Rapport and A. Gorio, eds., Raven Press, New York, p. 17 (1981).
P. J. Richardson, Presynaptic distribution of the cholinergic specific antigen chol-1and 5′-nucleotidase in rat brain, as determined by complement-mediated release of neurotransmitters, J. Neurochem. 41:640 (1983).
J. Holmgren, L. Lindholm, O. Nilsson, T. Lagergard, B. Persson, and L. Svennerholm, Detection of CA-50, a monoclonal antibody-defined cancer-associated antigen, in serum from tumor patients, in: “Glycoconjugates, Proc. 7th Internat. Symp.”, M. A. Chester, D. Heinegard, A. Lundblad, and S. Svensson, eds., Lund-Ronneby, Sweden, p. 850 (1983).
S. S. Ahn, R. F. Irie, T. H. Weisenburger, P. C. Jones, G. Juillard, D. J. Roe, and D. L. Morton, Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response, Surgery 92:362 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Rapport, M.M., Huang, Yy. (1984). Present Status of the Immunology of Gangliosides. In: Ledeen, R.W., Yu, R.K., Rapport, M.M., Suzuki, K. (eds) Ganglioside Structure, Function, and Biomedical Potential. Advances in Experimental Medicine and Biology, vol 174. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1200-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1200-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1202-4
Online ISBN: 978-1-4684-1200-0
eBook Packages: Springer Book Archive